Canine N-MID OC antibody and antigen (recombinant protein)
Diagnostic anti-Canine N-MID OC antibodies pairs and antigen for animal health (animal Dog/Canine osteoporosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-N-MID-OC-Ag01 | Recombinant Canine N-MID OC protein | 3090 |
GMP-CAN-N-MID-OC-Ab01 | Anti-Canine N-MID OC mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-N-MID-OC-Ab02 | Anti-Canine N-MID OC mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-N-MID-OC-Ab03 | Anti-Canine N-MID OC human monoclonal antibody (mAb) | 1953 |
GMP-CAN-N-MID-OC-Ab04 | Anti-Canine N-MID OC human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-N-MID-OC-Ag01 |
Product Name | Recombinant Canine N-MID OC protein |
Target/Biomarker | Canine N-terminal midfragment of Osteocalcin (N-MID OC) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine N-terminal midfragment of Osteocalcin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in N-MID OC level test of animal Dog/Canine with osteoporosis. |
Tag | His |
Products description | Recombinant Canine N-MID OC protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-N-MID-OC-Ab01, GMP-CAN-N-MID-OC-Ab02 |
Product Name | Anti-Canine N-MID OC mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine N-terminal midfragment of Osteocalcin (N-MID OC) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine N-terminal midfragment of Osteocalcin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies in N-MID OC level test of animal Dog/Canine with osteoporosis. |
Tag | mFc |
Products description | Anti-Canine N-MID OC mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-N-MID-OC-Ab03, GMP-CAN-N-MID-OC-Ab04 |
Product Name | Anti-Canine N-MID OC human monoclonal antibody (mAb) |
Target/Biomarker | Canine N-terminal midfragment of Osteocalcin (N-MID OC) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine N-terminal midfragment of Osteocalcin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies in N-MID OC level test of animal Dog/Canine with osteoporosis. |
Tag | hFc |
Products description | Anti-Canine N-MID OC human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Canine N-MID Osteocalcin (N-MID OC) is not just a biomarker; it is a remarkable gateway to understanding the intricate dance of bone metabolism in dogs. Structurally, N-MID OC represents a fragment of the osteocalcin protein, synthesized predominantly by osteoblasts, the architects of bone formation. This remarkable biomarker emerges from the N-terminal end of the osteocalcin molecule, signifying its active participation in the orchestration of canine skeletal health. Osteocalcin's role transcends mere structural support. It is a crucial player in bone mineralization, promoting the deposition of calcium and phosphate in the bone matrix. This ensures the resilience and integrity of bone tissue, underpinning a dog's agility and mobility. Furthermore, N-MID OC doesn't confine its influence to the skeletal realm alone. It extends its reach to the broader domain of canine physiology. N-MID OC communicates with other organs and tissues, orchestrating an interplay that influences energy metabolism and insulin sensitivity. This multifaceted role endows N-MID OC with the status of a metabolic regulator, with implications for overall canine health and well-being. Beyond its structural and metabolic functions, N-MID OC holds the power to unravel the secrets of canine bone remodeling. It provides us with a window into the dynamic processes governing bone health in dogs. The insights gained from N-MID OC measurements enable us to delve into the intricacies of canine bone turnover, offering a comprehensive view of the canine skeletal system's resilience and adaptability.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.